Physician profile
Jugal Rakesh Dharia
NPI 1174940449
$308,871.68
in general payments reported to CMS, 2019-2025
35 companies · $303K in 2025
The $303K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $157 · 2021: $399 · 2022: $2,853 · 2023: $698 · 2024: $342 · 2025: $303K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $302K · Food and Beverage: $1,687 · Travel and Lodging: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $302,400.00 |
| Food and Beverage | $1,687.10 |
| Travel and Lodging | $341.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $302,520.33 | 2023-2025 | |
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2022 | |
| Triad Life Sciences INC. | $1,063.77 | 2022 | |
| Zimmer Biomet Holdings, INC. | $970.57 | 2019-2022 | |
| Paragon 28, INC. | $554.11 | 2025 | Monkey Rings |
| Smith+Nephew, INC. | $456.97 | 2019-2025 | Grafix Pl, Collagenase Santyl, Pico 7 |
| Organogenesis INC. | $409.42 | 2021-2023 | Puraply |
| Stryker Corporation | $263.97 | 2020-2025 | Prostep Mica, N/A, Ortholoc 3di |
| Bioventus LLC | $180.93 | 2022 | |
| Averitas Pharma INC. | $164.31 | 2023-2025 | Qutenza |
| Progenacare Global, LLC | $161.30 | 2023 | |
| Cook Medical LLC | $145.19 | 2024 | Zilver Vena, Cook Celect |
| Integra Lifesciences Corporation | $122.58 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $58.71 | 2019-2023 | Krystexxa |
| Biocomposites INC | $47.95 | 2025 | Stimulan |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $44.57 | 2021 | |
| Paratek Pharmaceuticals, INC. | $44.46 | 2022-2024 | Nuzyra |
| Novastep INC. | $43.79 | 2025 | Nexis |
| Sebela Pharmaceuticals INC. | $38.60 | 2021-2023 | Naftin, Pramosone |
| Hydrofera LLC | $36.34 | 2023 | Hydrofera Blue |
| Ibsa Pharma INC. | $36.24 | 2020-2023 | Tirosint, Licart |
| Melinta Therapeutics, LLC | $34.76 | 2022-2023 | Kimyrsa |
| Ani Pharmaceuticals, INC. | $33.96 | 2025 | Oxistat |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.75 | 2021-2022 | |
| Depuy Synthes Sales INC. | $31.65 | 2021 | |
| Hikma Pharmaceuticals USA | $30.69 | 2019-2020 | |
| Nevro Corp. | $23.35 | 2023 | Senza |
| Osteomed LLC | $18.64 | 2020 | |
| Linvatec Corporation | $18.36 | 2025 | Hercules Suture Anchor System, Allograft Tissue, Biobrace 23mm |
| Reapplix INC. | $16.00 | 2023 | 3c Patch Kit - Box |
| Sandoz INC. | $15.84 | 2021 | |
| Orthofix Medical, INC. | $15.67 | 2023 | Physio-Stim, Spinal-Stim |
| Merck Sharp & Dohme LLC | $13.42 | 2019 | |
| Tactile Systems Technology INC | $12.45 | 2020 | |
| Kerecis Limited | $10.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jugal Dharia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.